Detalhes bibliográficos
Ano de defesa: |
2017 |
Autor(a) principal: |
Rocha, Raysa Manuelle Santos |
Orientador(a): |
Quintans Júnior, Lucindo José |
Banca de defesa: |
Não Informado pela instituição |
Tipo de documento: |
Dissertação
|
Tipo de acesso: |
Acesso aberto |
Idioma: |
por |
Instituição de defesa: |
Não Informado pela instituição
|
Programa de Pós-Graduação: |
Pós-Graduação em Ciências da Saúde
|
Departamento: |
Não Informado pela instituição
|
País: |
Não Informado pela instituição
|
Palavras-chave em Português: |
|
Palavras-chave em Inglês: |
|
Área do conhecimento CNPq: |
|
Link de acesso: |
https://ri.ufs.br/handle/riufs/6692
|
Resumo: |
Hepatitis C implications go beyond liver complications, reflecting on systemic metabolic manifestations with consequent deleterious effect on the disease’s clinical course. In view of the pathogenic association between hepatitis C and metabolic dysfunctions, it was justified to perform this study in the care reference center of patients with hepatitis C diagnosis in the State of Sergipe, Brazil, in order to evaluate the anthropometric and metabolic profile evolution of these individuals in triple therapy and nutritional monitoring. This is an observational and descriptive study conducted with data from clinical and nutrition records of patients with chronic hepatitis C, adults or elderly patients in triple therapy attended at the University Hospital of Sergipe’s outpatient clinic. The individual diet plan was delivered after the first nutritional consultation and before the drug therapy start. Anthropometric evaluations were performed, data were collected from the biochemical profile and the extent of sustained virological response was analyzed after the end of drug treatment. It was observed a reduction at the percentage of subjects at risk (p = 0.002) and at substantially increased risk (p <0.001) for waist circumference (WC), and reduction of the percentage of individuals at risk (p <0.001) according to waist-to-height ratio (WHtR). There was a significant reduction in fasting blood glucose (p = 0.014), total cholesterol (p <0.001) and LDL cholesterol (p <0.001).In addition, there was a significant reduction in the prevalence of subjects with altered fasting plasma glucose among patients who achieved sustained virological response and those who did not achieve therapeutic success. Based on these results, it is suggested that nutritional monitoring combined with drug therapy for patients with hepatitis C, provided a positive evolution of the anthropometric and metabolic parameters of the sample, which may represent an effective therapeutic approach in the fight against the systemic manifestations associated with hepatitis C. |